STELAZINE

This brand name is authorized in Brazil, Cyprus, Ireland, Malta, Mexico

Active ingredients

The drug STELAZINE contains one active pharmaceutical ingredient (API):

1 Trifluoperazine
UNII 214IZI85K3 - TRIFLUOPERAZINE

Trifluoperazine is one of the phenothiazine class of compounds and as such has many pharmacodynamic effects which relate to its therapeutic actions and side effects. The most notable action of phenothiazines is antagonism at dopamine receptors in the CNS.

Read about Trifluoperazine

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
N05AB06 Trifluoperazine N Nervous system → N05 Psycholeptics → N05A Antipsychotics → N05AB Phenothiazines with piperazine structure
Discover more medicines within N05AB06

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: BR Câmara de Regulação do Mercado de Medicamentos Identifier(s): 510607501110419, 510607502117417
Country: MT Medicines Authority Identifier(s): AA565/96201
Country: MX Comisión Federal para la Protección contra Riesgos Sanitarios Identifier(s): 52027

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.